Gyroscope Therapeutics $148.0 million Series C equity financing
We advised Gyroscope Therapeutics on its private placement of preferred stock
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
loanDepot $600 million senior notes offering
We advised the initial purchasers on the high-yield debt offering
Solid Biosciences $143.75 million follow-on equity offering
We advised the joint book-running managers on the stock offering
European Biotech Acquisition $120 million IPO
We advised European Biotech Acquisition, a SPAC, on its IPO and Nasdaq listing
Jounce Therapeutics $64.7 million follow-on offering
We advised the underwriters on the equity offering
Shake Shack $250 million convertible senior notes offering
We advised the initial purchasers on the Rule 144A convertible notes offering
InflaRx $75 million follow-on offering
We advised the underwriters on the equity offering
Adtalem $800 million notes offering
We advised the initial purchasers on the high-yield notes offering
Ayala Pharmaceuticals $25 million private placement
We advised the placement agent on the private placement of stock and warrants
loanDepot $62 million IPO
The shares are listed on the New York Stock Exchange